Clinical Trial Update: Antitumor-B KAC PK Study [Phase 1]

View source ↗

Summary

A Phase 1 trial of Antitumor-B KAC PK for squamous cell carcinoma of the oral cavity has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Oral Cavity

Drugs mentioned

• Antitumor-B KAC

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Squamous Cell Carcinoma of the Oral Cavity | Phase 1 | Status: WITHDRAWN